Cancer Immunotherapy /

For some time immunotherapy has been heralded as a breakthrough approach for cancer treatment. Although the potential of this strategy remains solid, the approach needs considerable refinement. Whilst some programmes are looking to increase the understanding of molecular and cellular mechanisms unde...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Άλλοι συγγραφείς: Allison, James P. (Επιμελητής έκδοσης), Dranoff, Glenn (Επιμελητής έκδοσης), Alt, Frederick W. (Επιμελητής έκδοσης)
Μορφή: Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: Amsterdam ; Boston : Elsevier Academic Press, 2006.
Σειρά:Advances in immunology ; v. 90.
Θέματα:
Διαθέσιμο Online:Full Text via HEAL-Link
LEADER 04408nam a2200673 4500
001 ocn123451846
003 OCoLC
005 20180501121910.0
006 m o d
007 cr cnu---unuuu
008 070424s2006 ne af ob 001 0 eng d
040 |a N$T  |b eng  |e pn  |c N$T  |d YDXCP  |d OCLCQ  |d MERUC  |d UBY  |d E7B  |d NRU  |d OCLCQ  |d IDEBK  |d QCL  |d OCLCQ  |d OPELS  |d OCLCQ  |d NLGGC  |d OPELS  |d OCLCF  |d S4S  |d OCLCQ  |d EBLCP  |d OCLCQ  |d OTZ  |d OCLCQ  |d ESU  |d OCLCQ  |d OCLCO  |d OCLCA  |e rda  |d MEU  |d GrThAP 
019 |a 148354255  |a 154703088  |a 441763217  |a 505085518  |a 647616981  |a 695557832  |a 823857082  |a 823927154  |a 824116793  |a 824168569  |a 935261431 
020 |a 9780080463445  |q (electronic bk.) 
020 |a 0080463444  |q (electronic bk.) 
020 |a 0080463371  |q (electronic bk.) 
020 |a 9780080463377  |q (electronic bk.) 
020 |a 0120224895  |q (electronic bk.) 
020 |a 9780120224890  |q (electronic bk.) 
020 |a 1280635711 
020 |a 9781280635717 
035 |a (OCoLC)123451846  |z (OCoLC)148354255  |z (OCoLC)154703088  |z (OCoLC)441763217  |z (OCoLC)505085518  |z (OCoLC)647616981  |z (OCoLC)695557832  |z (OCoLC)823857082  |z (OCoLC)823927154  |z (OCoLC)824116793  |z (OCoLC)824168569  |z (OCoLC)935261431 
050 4 |a RC271.I45  |b C35 2006eb 
060 4 |a QW 940 
072 7 |a MED  |x 062000  |2 bisacsh 
072 7 |a HEA  |x 039030  |2 bisacsh 
072 7 |a K  |2 bicssc 
082 0 4 |a 616.99/4061  |2 22 
084 |a 42.31  |2 bcl 
084 |a 44.45  |2 bcl 
049 |a TEFA 
245 0 0 |a Cancer Immunotherapy /  |c edited by James P. Allison, Glenn Dranoff ; series editor, Frederick W. Alt. 
264 1 |a Amsterdam ;  |a Boston :  |b Elsevier Academic Press,  |c 2006. 
300 |a 1 online resource (xvi, 383 pages, 8 unnumbered pages of plates) :  |b illustrations (some color). 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
490 1 |a Advances in immunology,  |x 0065-2776 ;  |v v. 90 
546 |a Text in English. 
504 |a Includes bibliographical references and index. 
505 0 |a Cancer immunosurveillance and immunoediting / Mark J. Smyth, Gavin P. Dunn, and Robert D. Schreiber -- Mechanisms of immune evasion by tumors / Charles G. Drake, Elizabeth Jaffee, and Drew M. Pardoll -- Development of antibodies and chimeric molecules for cancer immunotherapy / Thomas A. Waldmann and John C. Morris -- Industion of tumor immunity following allogeneic stem cell transplatnation / Catherine J. Wu and Jerome Ritz -- Vaccination for treatment and prevention of cancer in animal models / Federica Cavallo [and others] -- Unraveling the complex relationship between cancer immunity and autoimmunity / Hiroshi Uchi [and others] -- Immunity to melanoma antigens / Craig L. Slingluff [and others] -- Checkpoint blackade in cancer immunotherapy / Alan J. Kroman, Karl S. Peggs, and James P. Allison -- Combinatorial cancer immunotherapy / F. Stephen Hodi and Glenn Dranoff. 
520 |a For some time immunotherapy has been heralded as a breakthrough approach for cancer treatment. Although the potential of this strategy remains solid, the approach needs considerable refinement. Whilst some programmes are looking to increase the understanding of molecular and cellular mechanisms underlying the stimulation of antitumor immunity, others are trying to find the most appropriate clinical setting that will reveal the role of the immune system in combating cancer. Among the most important discoveries have been tumor-specific antigens. This thematic volume highlights some key issues. 
588 0 |a Print version record. 
650 0 |a Cancer  |x Immunotherapy. 
650 2 |a Immunotherapy.  |0 (DNLM)D007167 
650 2 |a Antigens, Neoplasm.  |0 (DNLM)D000951 
650 2 |a Tumor Escape.  |0 (DNLM)D019139 
650 7 |a MEDICAL  |x Oncology.  |2 bisacsh 
650 7 |a HEALTH & FITNESS  |x Diseases  |x Cancer.  |2 bisacsh 
650 7 |a Cancer  |x Immunotherapy.  |2 fast  |0 (OCoLC)fst00845386 
650 1 7 |a Immunotherapie.  |2 gtt 
650 1 7 |a Kanker.  |2 gtt 
655 4 |a Electronic books. 
700 1 |a Allison, James P.,  |e editor. 
700 1 |a Dranoff, Glenn,  |e editor. 
700 1 |a Alt, Frederick W.,  |e editor. 
776 0 8 |i Print version:  |t Cancer immunotherapy.  |d Amsterdam ; Boston : Elsevier Academic Press, ©2006  |z 0120224895  |z 9780120224890  |w (OCoLC)68135864 
830 0 |a Advances in immunology ;  |v v. 90. 
856 4 0 |u https://www.sciencedirect.com/science/bookseries/00652776/90  |z Full Text via HEAL-Link